INVESTMENT SECURITIES, RELATED PARTY (Details) - USD ($)	Sep. 30, 2022	Sep. 30, 2021
Prepaid Expenses	$ 20,945	$ 48,144
Accrued Interest Receivable	0	230
Accounts Payable	28,799	$ 91,498
Notes Payable, Related Parties, Current	710
Common Stock [Member] | Zander Therapeutics
Fair Value of Intellectual Property	1,500
Prepaid Expenses	65,661
Due from Employee	1,071
Note Receivable	64,400
Accrued Interest Receivable	23,989
Investment Securities	8,423,366
Convertible Note Receivable	10,000
Accounts Payable	1,269,041
Notes Payable	400,000
Accrued Expenses, Related Party	162,011
Notes Payable, Related Parties, Current	5,396
Accrued Expenses	203,037
Enterprise Value	10,563,930
Less: Total Debt	(2,038,343)
Portion of Enterprise Value attributable to Shareholders	$ 8,525,587
Fair Value per share	$ 0.186168
Series M Preferred Stock [Member] | Zander Therapeutics
Fair Value of Intellectual Property	$ 1,500
Prepaid Expenses	65,661
Due from Employee	1,071
Note Receivable	64,400
Accrued Interest Receivable	23,989
Investment Securities	8,423,366
Convertible Note Receivable	10,000
Accounts Payable	1,269,041
Notes Payable	400,000
Accrued Expenses, Related Party	162,011
Notes Payable, Related Parties, Current	5,396
Accrued Expenses	203,037
Enterprise Value	10,563,930
Less: Total Debt	(2,038,343)
Portion of Enterprise Value attributable to Shareholders	$ 8,525,587
Fair Value per share	$ 0.186168